Tom40 is the channel forming subunit of the translocase of the mitochondrial outer membrane (TOM complex), essential for protein import into mitochondria. Tom40 is synthesized in the cytosol and contains information for its mitochondrial targeting and assembly. A number of stable import intermediates have been identified for Tom40 precursors in fungi, the first being an association with the sorting and assembly machinery (SAM) of the outer membrane. By examining the import pathway of human Tom40, we have been able to elucidate additional features in its import. We identify that Hsp90 is involved in delivery of the Tom40 precursor to mitochondria in an ATPdependent manner. The precursor then forms its first stable intermediate with the outer face of the TOM complex before its membrane integration and assembly. Deletion of an evolutionary conserved region within Tom40 disrupts the TOM complex intermediate and causes it to stall at a new complex in the intermembrane space that we identify to be the mammalian SAM. Unlike its fungal counterparts, the human Tom40 precursor is not found stably arrested at a SAM intermediate. Nevertheless, we show that Tom40 assembly is reduced in mitochondria depleted of human Sam50. These findings are discussed in context with current models from fungal studies.
INTRODUCTION
The process of protein import into mitochondria has been well characterized (1) (2) (3) (4) . Tom40 is the central and essential component of the translocase of the outer mitochondrial membrane (TOM 1 ), involved in the translocation and sorting of proteins into the organelle (5, 6) . Tom40 is found in a multi-subunit complex consisting of the receptor proteins Tom20, Tom70 (7), a central organizing subunit Tom22 involved in complex stability (8), and three small proteins Tom5, Tom6 and Tom7 (9) (10) (11) . A ~400 kDa complex is well resolved via blue-native gel electrophoresis (BN-PAGE) and contains all subunits except Tom70 and usually Tom20 (12) (13) (14) . A similar sized complex is found in mammalian mitochondria (15, 16) although genes encoding Tom5 and Tom6 counterparts have not been found in the genome.
Almost all mitochondrial proteins employ the TOM machinery for their import since the vast majority are encoded by nuclear genes, synthesized in the cytosol and subsequently trafficked into the organelle. Likewise, the TOM subunits must also be targeted to mitochondria and following their integration into the membrane, are assembled into new TOM complexes. While the import and assembly of individual TOM subunits has been studied in some detail, it seems that Tom40 follows a unique pathway for its biogenesis (17, 18) . In vitro import studies in fungi have shown that Tom40 precursors can be arrested in stable intermediates, the first of which is a 250 kDa complex containing the Tom40 precursor associated with the recently-identified sorting and assembly machinery (SAM) of the outer membrane (19) (20) (21) (22) (23) . The SAM complex consists of a number of subunits including Sam50 (Tob55/Omp85), (19, 21, 24) , Sam35 (Tob38/Tom38) (25) (26) (27) and Sam37 (Mas37/Tom37) (20) . How this complex is involved in the integration of Tom40 and other β-barrel proteins into the outer membrane is not yet known. Following its integration into the outer membrane, the Tom40 precursor binds small TOM subunits before its assembly into the TOM complex (28) . This final step requires recruitment of Tom22 via an interaction with Mdm10, which associates with the SAM complex (29) .
The steps before Tom40 associates with the SAM complex have not been well-characterized owing to the lack of detectable intermediates. However it has been shown that Tom40 precursors require ATP for their initial targeting to mitochondria suggesting that cytosolic chaperones may be involved (17, 30) . Furthermore it has been proposed that Tom40 precursors initially interact with TOM receptors and also the TOM complex itself before being transferred to SAM. Integration of Tom40 into the outer membrane seems to occur via the intermembrane space (IMS) side (28, 31) and this has recently been supported by studies showing that the IMS small Tim proteins facilitate this process (32, 33) . These findings suggest that the Tom40 precursor must first translocate across the outer membrane, presumably through preexisting Tom40 channels. How the Tom40 precursor is directed to the mitochondrion and engages with members of the TOM and SAM machinery is not known.
In order to address some of these questions, we investigated the biogenesis of human Tom40 (hTom40). We show that hTom40 is kept import competent by the cytosolic chaperone Hsp90. In addition we identify a stable association between human Tom40 precursors and the TOM complex but not with the SAM complex. Deletion of an evolutionary conserved stretch of amino acids causes the precursor to bypass stable intermediate formation with the TOM complex and instead it stalls at a complex of lower size that we show to be the human SAM complex.
EXPERIMENTAL PROCEDURES
Cloning procedures -The cDNA encoding human Tom40 (15; Accession number BC017224) was obtained from the I.M.A.G.E. Consortium (MRC Cambridge) . The Tom40 open reading frame (ORF) was amplified by the polymerase chain reaction (PCR) and subsequently cloned into the vectors pGEM-4Z (Promega) and pCAGGS (34) . For construction of a Tom40-GFP fusion protein, the human Tom40 ORF lacking its stop codon was cloned into the vector pE-GFP (CLONTECH) at EcoR I and BamH I sites and in-frame with the GFP coding region. A similar approach was employed for construction of a vector to encode GFP fused at the N-terminus of Tom40. For construction of Tom40 N-terminal truncations, PCR of appropriate regions of the Tom40 ORF was performed followed by their ligation into pE-GFP.
The cDNA encoding human Sam50 (Accession number: AAH11681) was obtained from the I.M.A.G.E. Consortium. For creation of a hSam50-GFP fusion construct, the hSam50 ORF lacking its stop codon was cloned into the pE-GFP vector at Sal I and Not I in-frame with the GFP ORF. Similarly, for creation of a GFP-hSam50 fusion construct the hSam50 ORF was amplified and cloned at BamH I and Not I into a modified form of the pE-GFP vector, to give in-frame C-terminal fusions to GFP. For creation of a HA-hSam50 fusion, the hSam50 ORF was cloned at Sal I and Not I of the pME-HA vector (35) .
For
RNA interference studies, two complementary oligonucleotides (Sense: 5'  GATCCGGTGATGACGCACTTCCAATTCAAG  AGATTGGAAGTGCGTCATCACCTTTTTTGG  AAA  3'  and  Antisense: 5' TTTCCAAAAAAGGTGATGACGCACTTCCAA TCTCTTGAATTGGAAGTGCGTCATCACCGG ATC 3') were designed specific for hSam50 depletion using pSilencer vectors according to the manufacturer's instructions (Ambion Inc). The oligonucleotides were annealed and cloned into pSilencer 3.0-H1 at Bam HI and Hind III sites. A control plasmid containing a scrambled sequence (36) was also employed. All clones were verified by DNA sequencing.
Plasmids expressing human Tom20 (37), Tom22 (38) , and p-OTC (39) were published previously.
Cell culture and transfection -Cells were cultured in Dulbecco's Modified Eagle's Medium (GIBCO-BRL) containing 10% (v/v) fetal calf serum at 37°C under an atmosphere of 5% CO 2 and 95% air. Cells growing on coverslips in 2 cm wells or in 9 cm plates were transfected with 2 or 10 µg plasmid DNA respectively, using Lipofectamine 2000, according to manufacturer's instructions (Invitrogen). For microscopic analysis, cells were incubated with 80 nM MitoTracker Red CMXRos (Molecular Probes) for 30 min before mounting coverslips onto glass slides. For immunofluorescence, cells were fixed in paraformaldehyde, washed in phosphate buffered saline containing 0.1% (v/v) Triton X-100 and incubated with appropriate antibodies (36) . Cells were visualized using an Olympus BX-50 fluorescence microscope with a 100x oil immersion objective. Images were captured with a SPOT RT 3CCD camera (Diagnostic Instruments) and processed using SPOT Advanced software (Version 3.4).
In vitro transcription and translation -Plasmid DNA or PCR products (40) were used for in vitro transcription using SP6 RNA Polymerase (Promega). In vitro translation of the RNA transcripts using rabbit reticulocyte lysates (Promega) in the presence of [ 35 S] methionine/cysteine (TRANS-Label, ICN Biomedicals) was performed as previously described (40) . In some cases, hTom40 was in vitro transcribed/translated using a coupled system (Promega).
In vitro import and assembly assaysMitochondria were isolated from tissue culture cells (HEK 293T, HT1080 or HeLa) grown as monolayers according to (16) . For in vitro protein import studies, 35 S-labeled proteins were incubated with isolated mitochondria at 20°C or 37°C for various times as indicated in the figures. Samples were subjected to various treatments as previously described (40) . BN-PAGE was performed according to Simpson et al. (41) . All mitochondrial pellets were resuspended in digitonin-containing buffer (1% [w/v] digitonin, 50 mM NaCl, 10% [v/v] glycerol, 20 mM Bis-Tris pH 7.0). BN-PAGE antibody shift assays were undertaken as previously described (16) .
Inhibition assays with C-90 and C-Bag proteinsPlasmids coding for hexa-histidine tagged Cterminal domain of Hp90 (C-90) and the Cterminal domain of Bag-1 (C-Bag) were obtained from Jason Young (Munich) (42) . Purification of hexa-histidine tagged recombinant proteins was carried out using nickel-nitrilotriacetic agarose (Ni-NTA) under native conditions according to the manufacturer's instructions (Qiagen). Purified proteins were subsequently dialyzed in import buffer minus sucrose (5 mM MgOAc, 80 mM KOAc, 1 mM DTT, 0.1 mM ADP, 10 mM NaSuccinate, 20 mM Hepes-KOH pH 7.4). Inhibition assays were performed according to Young et al. (42) . Inhibitory recombinant protein (C-90 or C-Bag) or control BSA (20 µM final concentration) was added to [ 35 S]-hTom40 in 150 µl import buffer in the presence of 2.5 mM ATP.
After pre-incubation at 37°C for 5 min, mitochondria were added and incubated for various times. After import, mitochondria were reisolated, washed and solubilized in 1% (w/v) digitonin buffer and subjected to BN-PAGE (40) .
Antibodies -Antibodies specific for Tom20 and Tom22 were raised in rabbits (38) . Antibodies to hTom40 and hSam50 were raised against hexahistidine-tagged recombinant protein, expressed in E. coli and purified using Ni-NTA agarose (Qiagen) chromatography under denaturing conditions. Antigens were precipitated by dialysis against phosphate buffered saline and injected into rabbits using Freund's complete adjuvant and (for subsequent boosts) Freund's incomplete adjuvant. Antibodies against cytochrome c were purchased from BD Biosciences.
Miscellaneous -Tris-Tricine SDS-PAGE was performed as previously described (43) . Radiolabeled preproteins were detected using PhosphorImage storage technology and quantitated using IMAGEQUANT software (Molecular Dynamics). Western blotting was performed using a semi-dry transfer method (44) . Immunoreactive proteins from blots were detected using horseradish peroxidase coupled secondary antibodies and SuperSignal West Pico chemiluminescent substrate (Pierce Co.). Images were obtained using a ChemiGenius chemiluminescence detection system (SynGene). The hTom40 topology prediction was performed based on a hidden Markov method using the web server program PRED-TMBB (http://bioinformatics2.biol.uoa.gr/PRED-TMBB/input.jsp) (45).
RESULTS

hTom40 assembly intermediates
In order to analyze the assembly pattern of hTom40, we incubated in vitro translated [
35 S]-hTom40 with mitochondria isolated from cultured human osteosarcoma (HT1080) cells for varying times at 37°C and complexes were subjected to BN-PAGE analysis. As can be seen (Fig. 1A) , [ 35 S]-hTom40 assembled into a number of resolvable complexes in a time-dependent manner. At short incubations, hTom40 precursors were found in a ~500 kDa complex (termed "I"; lanes 1-2), while after longer incubations they assemble in a smaller ~100 kDa complex (II), before finally accumulating in a ~380 kDa complex (lane 4). The latter complex is identical in size to the mature TOM complex as verified by immunodecoration with anti-Tom40 and anti-Tom22 antibodies (lanes 5 and 6). In some cases, hTom40 precursors were also found in a poorly-resolved, high molecular weight species. Since western blot analysis shows that pre-existing Tom40 molecules are found in a single resolvable TOM complex at ~380 kDa (lane 5), the other complexes observed during the import of Tom40 precursors most likely represent kineticallytrapped assembly intermediates (28) . Indeed, we found that [ 35 S]-hTom40 could be arrested specifically at the 500 kDa intermediate I complex after incubating with mitochondria for 5 minutes at 20°C (Fig. 1B, lane 1 and 7 ). After performing a chase at 20°C, the radiolabel in the 500 kDa complex reduced in intensity, accompanied by some increase in the intensity of complex II. In contrast, performing the chase at 37°C resulted in the loss in intensity of the 500 kDa species with the corresponding assembly of Tom40 precursors into complex II and, more strongly, into the mature TOM complex (Fig. 1B, lanes 7-12) . The profile of hTom40 assembly was verified in mitochondria isolated from other tissue culture cell lines (data not shown). Thus, we conclude that in human cells, Tom40 precursors first assemble into a 500 kDa intermediate before their maturation into the TOM complex via a 100 kDa intermediate. In contrast, in yeast, Tom40 precursors first stably associate with a protease-resistant SAM complex of ~250 kDa, followed by its membrane insertion into a 100 kDa complex before its final assembly into the TOM complex (17, 28). The assembly pattern found for hTom40 resembles that of its yeast counterpart except that the size of the initial assembly intermediate I is significantly larger. While this size difference is puzzling, it has been suggested that the SAM complex in yeast observed by BN-PAGE is the core complex since additional SAM subunits may dissociate from the complex following membrane solubilization (29) . Thus the first assembly intermediate seen for hTom40 precursors might be an association with a more stable SAM complex present in human mitochondria. However, unlike the SAM-arrested Tom40 seen in yeast, the hTom40 precursor arrested at assembly intermediate I was accessible to externally added protease (Fig. 1C , compare lanes 1 and 2). In contrast, when hTom40 was imported for longer times and assembled into the TOM complex, it was largely resistant to the addition of external protease, with the reduction in size of the complex corresponding to the shaving of the cytosolic domain of Tom22 (16, 38) . The intermediate complex I might therefore represent the hTom40 precursor associated with the TOM complex.
Tom40 has been shown to require TOM receptors for its initial recognition at the mitochondrial surface (15, 30) . While indirect studies have suggested that yeast Tom40 precursors first interact with the TOM complex before being passed on to the SAM complex (19, 20) . Up to now however, a stable interaction between native Tom40 precursors and the TOM complex has not been shown. Standard western blot analysis does not detect a larger TOM complex since the radiolabeled hTom40 precursor is present in only very small amounts (data not shown). We therefore employed a different technique -antibody shift analysis ( Fig. 1D ; 16, 46) . As can be seen, the intermediate complex is shifted with antibodies against Tom40 as expected. Antibodies to Tom22 also shifted the complex indicating that this protein is present in the 500 kDa complex with hTom40 precursors. Antibodies specific for cytosolic Hsp70 (Hsc70), the abundant outer membrane protein VDAC, or pre-immune serum did not shift the Tom40 containing intermediate. Antibodies to the receptors Tom20 and Tom70 also did not shift the complex, although these proteins do not remain with the TOM complex during the conditions used for BN-PAGE (16). Thus we conclude that the 500 kDa assembly intermediate represents hTom40 precursors stably arrested at the cytosolic face of the TOM machinery.
Human Tom40 precursors require Hsp90 for import. Yeast Tom40 translated from reticulocyte lysate has been shown to require ATP for its import (17, 47), thus suggesting that, at least in this in vitro system, mammalian chaperones are required. We sought to address the role of this ATP requirement using entirely mammalian components in an in vitro import. Following translation of hTom40, ATP was depleted from the lysate using the ATP-diphosphatase, apyrase and added to mitochondria also depleted of ATP. A time course of import and assembly ( Fig. 2A) showed that in the absence of ATP, hTom40 precursors accumulated at the high molecular weight position and did not form a stable 500 kDa intermediate. After 30 minutes incubation however, the hTom40 precursor assembled into the TOM complex but to a lesser extent than in the presence of ATP. The high molecular weight complex (labeled with an asterisk) resembles that of the ADP/ATP carrier (AAC) precursor which, in the absence of ATP, forms a high molecular weight complex with Tom70 oligomers, as well as other components of the TOM machinery (48, 49) and also Hsp90 (42). We therefore wondered whether the hTom40 precursor requires Hsp70 or Hsp90 to assist with its targeting and assembly into the mitochondrial membrane. To test this, we performed competition analyses using either the purified domain of C-Bag, which competitively binds to Hsc70, or the C-terminal domain of Hsp90 which serves as a dominant negative mutant by binding to Tom70 and preventing productive interaction with native Hsp90 (42). Addition of these purified recombinant proteins (Fig. 2B) to lysates containing hTom40 prior to the addition of mitochondria led to a decrease in the formation of the high molecular weight complex, in comparison to the BSA control (Fig. 2C) . In addition, the amount of Tom40 at intermediate I was lower in the presence of C-Bag as was the yield of fullyassembled hTom40 (lanes 5-8), indicating the involvement of Hsp70 in Tom40 targeting. Impairment of Hsp90 function whereas, led to stalling of hTom40 precursors at the TOM machinery (Intermediate I; Fig. 2C, lanes 9-12) . This indicates that Hsp90 is also required for driving the assembly of hTom40, perhaps by maintaining the precursor in an appropriate conformation. Loss of Hsp90 function may not prevent targeting of hTom40 to mitochondria, but may lead to improper folding of the precursor thereby blocking its import and assembly pathway. We therefore conclude that Hsp90, and to a lesser extent, Hsp70, play an important role in the import of hTom40 into mitochondria.
Tom22 levels regulate hTom40 progression from 100 kDa to the TOM complex. The 100 kDa Tom40 complex has been identified previously in yeast and Neurospora mitochondria and most likely represents Tom40 integrated into the mitochondrial outer membrane (17, 28). We have shown that human Tom7 also preferentially assembles into a similar sized complex prior to its assembly into the TOM complex (16) . In this case, the levels of Tom22 were found to regulate TOM complex assembly. We therefore asked whether Tom22 levels also influence the assembly efficiency of newly imported hTom40. In this case we used mitochondria isolated from HeLa cells which are known to contain limiting levels of hTom22 (16) . HeLa cells were transfected with empty vector or vector encoding Tom20 or Tom22, and mitochondria were then isolated. The levels of Tom20 and Tom22 were substantially increased in the respective preparation as observed by western blot analysis (Fig. 3A) . [ 35 S]-hTom40 was subsequently imported into these mitochondria for 15 min and 120 min and assembly monitored by BN-PAGE. As can be seen, after the 15 min incubation, a significant 100 kDa complex (intermediate II) was observed in control mitochondria and mitochondria over-expressing Tom20 (Fig. 3B, lanes 1 and 2) while in contrast, hTom40 precursors were found almost exclusively in the fully assembled complex in mitochondria containing increased levels of Tom22 (lane 3). At longer times, hTom40 was capable of assembly into the TOM complex in all preparations (lanes 4-6). These results suggest that the levels of free Tom22 regulate the assembly of hTom40 into mitochondria.
Human Tom40 targeting and assembly signals.
After surveying its import pathway, we next sought to address the signals required for hTom40 targeting and assembly within the mitochondrial outer membrane. Like many other proteins directed to the outer membrane, hTom40 contains no obvious mitochondrial targeting information for recognition with surface receptors. Mutational analysis has however identified key regions required for assembly of Neurospora Tom40 into the TOM complex, but its targeting signals have not been resolved (17, 50, 51). We first sought to determine whether either, or both, hTom40 termini are required to be exposed for targeting by making N-and C-terminal fusions to the reporter green fluorescent protein (GFP). These constructs were expressed in COS-7 cells and visualized by fluorescence microcopy. As can be seen (Fig. 4A) , hTom40 with GFP fused at its C-terminus can be targeted to mitochondria, as confirmed by colocalization with the fluorescence seen with the matrix stain MitoTracker Red. Furthermore, a close-up of the overlay of both fluorescence patterns showed that hTom40-GFP was found peripheral to the mitochondrial matrix, consistent with its location at the outer mitochondrial membrane (right panel, labeled "zoom"). In contrast, fusion of GFP to the N-terminal end of hTom40 prevented mitochondrial targeting of this construct, with the protein dispersed throughout the cytosol. Western blot analysis of cell extracts using antibodies specific to GFP (Fig. 4B) revealed that both hTom40 fusions were expressed and migrated at their expected sizes following SDS-PAGE. These findings show that hTom40 requires an exposed N-terminus, but not C-terminus for its targeting to mitochondria. We next sought to determine whether the hTom40-GFP fusion protein could assemble into the TOM complex. [
35 S]-hTom40-GFP or hTom40 precursors were incubated with mitochondria and subjected to BN-PAGE analysis. Human Tom40-GFP precursors formed high molecular weight intermediates similar to those formed by hTom40, including what seemed to be the initial TOM assembly intermediate I complex (Fig. 4C) . These complexes were protease sensitive. However, hTom40-GFP did not assemble into the final TOM complex indicating that some of its assembly information was impaired, perhaps due to the folded GFP domain preventing precursor translocation into the IMS. Consistent with expression studies, the GFPhTom40 fusion protein did not interact with mitochondria in vitro (data not shown). (Fig. 5A) , although the C-terminal end may also form an additional transmembrane strand. The Nterminal end of rat Tom40 was found experimentally to face the cytosol and the Cterminal end facing the intermembrane space (52) . The N-terminal end of hTom40 is proline rich and lacks sequence similarity between fungal Tom40 proteins. We made a hTom40 construct lacking amino acids 2 to 44 and fused it to GFP. Fluorescence microscopy of COS-7 cells expressing hTom40
An N-terminal conserved region is important
∆2-44 -GFP revealed that this construct was still able to target to mitochondria, displaying fluorescence properties identical to that of the full length hTom40-GFP fusion (Fig. 5B) . Expression of the truncated fusion protein was confirmed via western blot analysis (data not shown). To determine if this N-terminal region is important for assembly of hTom40 into the TOM complex, mitochondrial in vitro import and assembly assays were performed. As can be seen (Fig. 5C ), hTom40 ∆2-44 was still able to assemble into the TOM complex like hTom40, with the same assembly intermediates being observed. Thus, this N-terminal region in hTom40 is dispensable for its mitochondrial targeting and subsequent assembly with pre-existing wild type Tom40 and other TOM subunits within the complex. This finding is somewhat surprising given fusion of GFP to the N-terminus of hTom40 blocks mitochondrial targeting. Furthermore, residues 40-44 are predicted to form part of the first transmembrane β-strand (Fig. 5A) . These results suggest that this is probably not the case. It has however been shown that deletion of an evolutionary conserved region within the Nterminal portion of Neurospora Tom40 (residues 51-60), prevents its efficient assembly into the TOM complex (51) . These residues are predicted to form a loop between the first two transmembrane β-strands (Fig. 5A) . We therefore made a similar construct where we deleted residues 72-87 in hTom40. These residues are highly conserved across all species (51). Human Tom40 ∆72-87 fused to GFP was still capable of mitochondrial targeting when expressed in cells (Fig. 5B) , however when imported into mitochondria in vitro, the protein (lacking GFP) was unable to assemble into the TOM complex (Fig. 5C, lanes 9-12) . A complex however was resolved at ~200 kDa (marked " †"), comparable in size to yeast Tom40 precursors arrested at the SAM intermediate (28) . Furthermore this complex containing hTom40 ∆72-87 was not accessible to externally-added proteinase K (lane 12), indicating that it might be in the IMS. A similar stalled complex was observed in the assembly of the Neurospora Tom40 mutant precursor (51) and is consistent with it being in association with the SAM complex. Indeed, this complex was accessible to protease in mitochondria containing an opened intermembrane space as a result of hypotonic swelling (Fig. 5D, lane 4) . The precursor of ornithine transcarbamylase (OTC) that assembles into a trimer of ~120 kDa following its import into the matrix was not protease accessible in these mitochondria, thus demonstrating that swelling led specifically to rupture of the outer membrane (Fig. 4D, lanes 5 and 6) . we fused it to GFP and expressed it in COS-7 cells as a GFP fusion. Both N-and C-terminal GFP tagged hSam50 fusions were indeed targeted to mitochondria (Fig. 6A) . Although clearly mitochondrial, some cells expressing the GFP fusions also displayed a background cytosolic localization. To eliminate GFP as a potential hindrance for proper insertion into the outer membrane, we employed a construct expressing hSam50 with an N-terminal hemaglutinin (HA) tag. The HA-hSam50 fusion was also targeted to mitochondria although some cytosolic fluorescence was still evident (Fig. 6A) . Continued hSam50 expression led to impaired mitochondrial morphology and transfected cells had a short lifetime indicating that the fusion protein was toxic (data not shown). We generated antibodies to recombinant hSam50 purified from bacterial inclusion bodies. Western blot analysis of mitochondrial extracts detected a specific band at ~52 kDa, corresponding to the size of its in vitro translation product (data not shown). Treatment of intact mitochondria with proteinase K did not significantly reduce the signal of hSam50 or that of the control matrix Hsp70, but did lead to clipping of a cytosolically exposed domain of Tom22 (Fig.  6B) . Proteinase K treatment of mitochondria following rupture of the outer membrane by osmotic shock did however lead to the loss of Sam50 signal as well as the controls Tom40, Tom22 (using antibodies against the intermembrane space domain) and cytochrome c while leaving matrix Hsp70 protected as expected (Fig. 6C) . Human Sam50 nevertheless displayed characteristics of it being membrane integrated since it was not extracted into the supernatant fraction following alkali washing (Fig. 6C,  compare lanes 4 and 5) . The control integral membrane proteins Tom40 and Tom22 were also not extracted but the peripheral membrane protein cytochrome c and matrix soluble mtHsp70 were found in the supernatant fraction. Finally we showed through two-dimensional BN-PAGE and western blotting of digitonin-lysed mitochondria, that hSam50 is found in a protein complex of ~200 kDa, distinct from the ~380 kDa TOM complex (Fig. 6D) . We conclude that hSam50 is a mitochondrial outer membrane protein exposed to the intermembrane space and potentially in complex with itself or additional subunits.
Identification of a human
Knockdown of hSam50 impairs Tom40 assembly.
In order to address the possible role of hSam50 in Tom40 assembly, we performed knockdown experiments using RNA interference. Human epithelial kidney cells were transfected with plasmids expressing siRNA directed to Sam50 mRNA or a control scrambled sequence and mitochondria were isolated 72 hours later. Western blot analysis revealed a significant knockdown of the levels of Sam50 using siRNA directed to Sam50 when compared to the scrambled control siRNA, while those of mtHsp70 were similar in both preparations (Fig. 7A) . The levels of Tom40 were somewhat reduced in Sam50 knockdown cells suggesting that Sam50 does indeed influence Tom40 biogenesis. Radiolabeled hTom40 was imported into both control and Sam50-knockdown mitochondria for various times and assembly monitored by BN-PAGE. As can be seen, there was a significant reduction in the levels of fully assembled hTom40 (Fig. 7B) . The import and assembly of hTom22 was unaffected in Sam50 knockdown mitochondria (data not shown). A limitation to this experiment however is that the reduced amount of pre-existing hTom40 levels in Sam50 knockdown mitochondria might affect the subsequent import of incoming hTom40 precursors.
We therefore addressed the requirement for the mammalian SAM complex in a different way -by determining if the stalled ~250 kDa complex observed for hTom40 ∆72-87 represents an association with the SAM complex. After import of radiolabeled hTom40 ∆72-87 or hTom40
(as control), mitochondria were isolated and subjected to antibody shift analyses using BN-PAGE. As can be seen (Fig. 7C ), antibodies to hTom40 shifted all complexes containing hTom40
∆72-87
including the stalled complex (labeled " †") while antibodies against Tom22, and Metaxin 1 did not, similar to that of preimmune serum control (Lanes 6, 8, 10 ). Antibodies to Sam50 specifically shifted the stalled complex indicating that Sam50 is also present in this complex. These antibodies did not shift the 100 kDa Tom40 precursor intermediate, or the fully assembled TOM complex (lane 4). These results show that Sam50 is indeed involved in the assembly of Tom40 in humans thus demonstrating the conserved function of this protein in the biogenesis of Tom40.
DISCUSSION
Tom40 is predicted to form a β-barrel structure and like other members of this family, it contains cryptic targeting and assembly information. Not only must human Tom40 act as a protein translocase channel, but like its fungal counterpart, it also must form a stable association with other TOM subunits (at least Tom22 and Tom7 in humans) (15, 16) . The process by which Tom40 associates with single spanning, presumably α-helical, membrane proteins is not known. Furthermore, the way in which the Tom40 precursor is targeted to the mitochondrial surface is also not understood, nor the process of SAMmediated protein folding and membrane insertion. In order to understand some of these processes in more detail we undertook a study into the biogenesis of human Tom40. Such a study enables us to analyze the degree of conservation between fungal and mammalian cells which differ considerably in their biology, including a number of processes that occur directly at the cytosolicmitochondrial outer membrane interface (42, [56] [57] [58] .
In this report we identify an intermediate complex containing hTom40 precursors stably associated with the TOM machinery. This intermediate is observed before hTom40 precursor integration and assembly into the outer membrane. While the intermediate is stable to digitonin solubilization and native electrophoresis, the precursor is accessible to external protease treatment indicating that it is at least partially exposed to the cytosol. In yeast, it has been shown that the Tom40 precursor initially interacts with the TOM complex since blocking the TOM channel with a matrix targeted precursor prevents its association with the SAM complex (19) . The finding that a precursor can stably interact with the TOM machinery and be resolved by BN-PAGE has seldom been reported. In most cases, this has been shown by blocking precursor translocation via attachment to a folded protein domain (48) . Truscott et al. (2002) did however show by BN-PAGE that the precursor of the ADP/ATP carrier (AAC) can stably interact with the TOM complex in mitochondria from yeast cells containing mutant small Tim proteins of the IMS. These proteins are crucial to enable efficient translocation of the AAC precursor into the IMS (59). However, a very small amount of TOM-arrested AAC precursor was also observed in mitochondria isolated from wild type cells (46) . The stronger association observed for AAC and hTom40 precursors might reflect the fact that both are predicted to interact with the TOM machinery in a non-linear form (17, 49).
Depletion of ATP from the in vitro import system caused the hTom40 precursor to be arrested in a new large molecular weight complex on the outer mitochondrial face. We believe that this represents a macromolecular complex consisting of the hTom40 precursor with members of the TOM machinery as well as cytosolic chaperones. This is consistent with an earlier report suggesting that ATP is required for release of Neurospora Tom40 precursors from cytosolic chaperones (17). Furthermore, similar large molecular weight complexes consisting of Tom70 oligomers and other components have been previously observed by BN-PAGE with the AAC precursor in the absence of ATP (48, 49) . Up to now, the cytosolic factors involved in Tom40 precursor import have not been identified. Our experimental data supports a role of Hsp90, and possibly Hsp70, in delivery of hTom40 to the mitochondrial surface. Hsp70 inactivation caused a decrease in the import efficiency of hTom40. In contrast, inactivation of Hsp90 function still led to binding of the hTom40 precursor to the TOM complex; however its further progression along the assembly pathway was blocked. This suggests that the precursor is not in a proper folding state for translocation. This would be consistent with the finding that denatured proteins bind and block the TOM channel, while cytosolic chaperones can counteract this effect (60) . Given these findings, Hsp90 and Hsp70 are probably involved in binding the hTom40 precursor in the cytosol thereby maintaining it in an import competent state. Such a process is also consistent with the function of Hsp70/Hsp90 in the import of other precursor molecules into mitochondria (42, 61).
While a strong association was observed between Tom40 precursors and the TOM complex in human mitochondria, we were unable to detect a resolvable complex containing the hTom40 precursor bound to the SAM machinery. These observations led us to characterize the mammalian SAM complex. We found that the human Sam50 family member is indeed mitochondrial and like its yeast counterpart, resolves as a complex of ~200 kDa. Mitochondria depleted of hSam50 caused a decreased efficiency in assembly of hTom40 precursors, supporting the function of the SAM complex in β-barrel membrane protein assembly seen in yeast (19-21, 23, 48 ). While we were unable to detect a hTom40-SAM intermediate by BN-PAGE, we did observe a ~100 kDa complex similar to yeast. Assembly of hTom40 from the 100 kDa complex to the TOM complex is dependent on the levels of free hTom22 as demonstrated from our overexpression data. This is consistent with the function of Tom22 in assembly of the TOM complex (8, 16).
When we looked at targeting and assembly, it was surprising to find that fusion of GFP at the Nterminus of hTom40 abolished mitochondrial targeting, yet the first 44 residues of hTom40 were dispensable for its biogenesis. It is possible that attachment of the GFP β-barrel domain to the Nterminus altered the overall structure of hTom40 thereby preventing mitochondrial recognition. While hTom40 precursors lacking residues 72-87 were still targeted to mitochondria, they did not form any stable assembly intermediates and instead accumulated at the SAM complex. Residues 72-87 therefore contribute to membrane integration, folding and/or assembly of hTom40. Since this region is predicted to form a loop structure (Fig 5A) , shortening it might disrupt packing of transmembrane β-strands, leading to precursor stalling at the SAM complex. In addition, deletion of these residues seemed to abolish stable intermediate formation with the TOM complex, indicating that this predicted loop might be involved in binding to the TOM machinery. Alternatively, its deletion might alter the precursor structure such that it is more compact so that it translocates more efficiently across the Tom40 channel. While in vitro reconstitution experiments found that the first 165 residues of rat Tom40 are not required for channel formation (52) , our studies nevertheless show that at least some of these residues are essential for Tom40 biogenesis.
In conclusion, it seems that for fungi, a stable intermediate is seen with the SAM machinery while in mammals it is seen earlier -at the TOM machinery. This may indicate that upon translocation across the TOM machinery, human Tom40 is in a conformation more amenable for its insertion into the outer membrane, and hence a stable SAM intermediate is not observed. Yeast Tom40 precursors however, might not present such a barrier for their translocation across the outer membrane but then require additional conformational changes at the SAM complex. Indeed, yeast Tom40 precursors might require further interaction with the SAM machinery due to the existence of additional TOM subunits (Tom5 and Tom6) seemingly lacking in mammalian mitochondria. For yeast, assembly of the TOM complex has been shown to also require the involvement of Mdm10 (29), a protein that seems to be present only in fungi, possibly due to its additional role in attachment of mitochondria to the actin cytoskeleton in these cells (62) . 2) or in its final form in the TOM complex by incubating at 37°C for 120 min (lanes 3 and 4). Mitochondria were treated with 50 µg/ml proteinase K (PK) followed by BN-PAGE as in panel A. D, The 500 kDa assembly I intermediate was formed and mitochondria subsequently solubilized in digitonin buffer followed by incubation with antibodies to outer membrane proteins as well as preimmune serum or cytosolic Hsp70. Samples were subjected to BN-PAGE. Antibody shifted complexes are indicated. 35 S]-hTom40 was incubated with wild type mitochondria (from HT1080 cells) in the presence or absence of ATP for various times as indicated. Mitochondria were subjected to BN-PAGE analysis as outlined in Fig. 1 . B, C-90 and C-Bag recombinant proteins were purified, separated by SDS-PAGE and stained with co-omassie blue. C, [ 35 S]-hTom40 was added to mitochondria pre-incubated with equimolar concentrations of BSA (control), C-Bag or C-90. After incubation at 37°C for various times as indicated, samples were subjected to BN-PAGE analysis as outline above. and GFP-hTom40 (lane 3) were subjected to SDS-PAGE and western blot analysis using antibodies specific for GFP. C, [ 35 S]-hTom40 or hTom40-GFP were incubated with isolated wild type mitochondria (from HT1080 cells) for various times as indicated followed by treatment without (lanes 1-6) or with externally added PK (80 µg/ml; lanes 7-12) and analysis by BN-PAGE as outlined in Fig. 1 . were incubated with isolated wild type mitochondria (from HT1080 cells) for 45 min at 37°C. Samples were divided in two and one sample treated to outer membrane rupture by osmotic swelling. Samples were then treated with or without 100 µg/ml PK as indicated and subjected to BN-PAGE and Phosphorimage analysis. B, Mitochondria isolated from wild type HEK293T cells were treated with or without external PK (50 µg/ml) and subjected to SDS-PAGE and western blot analysis using antibodies raised against hSam50, the IMS domain of Tom22 and mtHsp70. C, Isolated wild type mitochondria were subjected to swelling in hypotonic buffer and treated with or without 50 µg/ml PK (lanes 2 and 3). Isolated mitochondria were subjected to alkaline extraction and separated into pellet (P) and supernatant (S) fractions (lanes 4 and 5). Proteins were separated by SDS-PAGE and subjected to western blot analysis using antibodies against hSam50, Tom40, the IMS domain of Tom22, cytochrome c and matrix Hsp70. D, Mitochondria solubilized in digitonin-buffer was subjected to BN-PAGE in the first dimension followed by SDS-PAGE in the second dimension. The gel was transferred to nitrocellulose and probed with antibodies against hSam50 and Tom40. Fig. 7 . Sam50 is required for assembly of human Tom40. A, Mitochondria were isolated from HEK293T cells transfected with pSilencer vector either expressing a scrambled sequence (control) or siRNA directed against hSam50 and proteins subjected to SDS-PAGE and western blot analysis using antibodies to mtHsp70, hTom40 and hSam50. B, [ 35 S]-hTom40 was incubated with control or Sam50 knockdown mitochondria for various times at 37°C. Mitochondria were isolated, resuspended in digitonin and subjected to BN-PAGE and Phosphorimage analysis. C, [ 35 S]-hTom40 or hTom40 ∆72-87 precursors were incubated with isolated wild type mitochondria (from HEK293T cells) for 60 minutes at 37 °C. Mitochondria were re-isolated, solubilized in digitonin-containing buffer followed by the addition of polyclonal antisera specific for the proteins as indicated. A preimmune serum control was also employed. 
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